Stocks With The Highest
Upside Forecast

Based on 25,000+ 1-year price targets provided by 5,000+ Wall Street analysts over the past 3-months

#	Name	Upside %	Analysts bullish %
1	1 Plus Therapeutics PSTV $35.4M	1,752% upside 3 price targets	0
2	2 Cabaletta Bio CABA $130M	1,358% upside 3 price targets	0
3	3 Biomea Fusion BMEA $89.5M	696% upside 4 price targets	0
4	4 Aclaris Therapeutics ACRS $166M	537% upside 4 price targets	0
5	5 Humacyte HUMA $354M	529% upside 3 price targets	0
6	6 ImmunityBio IBRX $2.16B	505% upside 3 price targets	0
7	SLN 7 Silence Therapeutics SLN $291M	459% upside 4 price targets	0
8	8 4D Molecular Therapeutics FDMT $297M	456% upside 3 price targets	0
9	9 Corbus Pharmaceuticals CRBP $114M	451% upside 3 price targets	0
10	10 Inovio Pharmaceuticals INO $72.9M	436% upside 3 price targets	0
11	11 Kura Oncology KURA $521M	420% upside 3 price targets	0
12	12 Korro Bio KRRO $130M	417% upside 3 price targets	0
13	13 Cardiff Oncology CRDF $176M	411% upside 3 price targets	0
14	CMPS 14 Compass Pathways CMPS $416M	349% upside 4 price targets	0
15	ALMS 15 Alumis Inc. Common Stock ALMS $426M	348% upside 4 price targets	0
16	16 Iovance Biotherapeutics IOVA $895M	329% upside 6 price targets	0
17	17 Prothena Corp PRTA $367M	329% upside 5 price targets	0
18	18 Lucid Diagnostics LUCD $108M	325% upside 3 price targets	0
19	19 ProQR Therapeutics PRQR $219M	301% upside 3 price targets	0
20	CAN 20 Canaan Creative CAN $303M	298% upside 4 price targets	0
21	21 Arcturus Therapeutics ARCT $334M	296% upside 3 price targets	0
22	22 Immuneering IMRX $121M	293% upside 4 price targets	0
23	23 Gossamer Bio GOSS $455M	283% upside 3 price targets	0
24	TECX 24 Tectonic Therapeutic, Inc. Common Stock TECX $387M	276% upside 4 price targets	0
25	25 Lexeo Therapeutics LXEO $249M	252% upside 4 price targets	0

12345

61